Abstracts

788 – Viral and Host Proteins Carried by Exosomes From PLWH Could Play a Role as Triggers of NADCs

Background A higher incidence and more rapid progression of several types of non-AIDS-defining cancer (NADC) have been reported in people living with HIV (PLWH). However, the exact mechanism linking HIV-1 infection to the development of NADCs is not yet fully understood. In vitro studies have suggested that viral molecules carried by exosomes derived from HIV-1-infected…

827 – Potential of the Short Chain Fatty Acid Caproic Acid in Protection Against CVD in HIV Infection

Background We have recently shown that the proinflammatory cytokine IL-32 is associated with arterial stiffness and cardiovascular disease in people with HIV (PWH). We also demonstrated that IL-32 induces coronary artery endothelial cell (CAEC) inflammation and dysfunction and that IL-32 alterations in PWH with subclinical atherosclerosis are associated with a deficit in the short-chain fatty…

800 – Predictors of Mortality Among Patients With Virus-Associated Cancers in a High HIV-Prevalence Region

Background Virus-associated cancers cause significant mortality in Africa. Understanding risk factors for mortality is crucial for effective prevention and treatment. We analyzed demographic and clinical characteristics of people with virus-associated cancers in Kisumu County, western Kenya – a region with a high HIV prevalence of 14.5% – and evaluate factors associated with mortality. Methods We…

829 – The Additive Value of Coronary Calcium in Identifying Cardiovascular Risk in Ageing People With HIV

Background In people without HIV, high Coronary Artery Calcium Scores (CACS) correlate with an increased risk of major cardiovascular and cerebrovascular events (MACE). HIV is independently associated with raised CACS, however data on factors associated with increased CACS and MACE (except smoking and diabetes) in HIV are scarce. Although knowledge on the importance of statin…

794 – Causes of Death Among Adults With HIV-Associated Kaposi Sarcoma in East Africa in the Treat All Era

Background In East Africa, one-year mortality following a diagnosis of HIV-associated Kaposi sarcoma (KS) in the Treat All era was recently estimated, in a community-derived sample, to be 41%.  To date, there is limited information on why these patients die.  Understanding causes of death among adults diagnosed with KS might improve management and, hence, survival or…

839 – Determinants of De-Novo High-Risk Carotid Ultrasound Features in Middle-Aged People Living With HIV

Background People living with HIV (PLWH) are at an elevated risk for cardiovascular and cerebrovascular events, often underestimated by traditional CVD risk scores. Identifying factors driving the progression of high-risk carotid ultrasound features, indicative of subclinical atherosclerosis, is essential for improving preventive strategies and outcomes in this population.  Methods This cohort study enrolled PLWH aged…

806 – The Ivorian Cervical Cancer Screening Cascade: A 10-Year Program Evaluation According to HIV Status

Background The 2030 global cervical cancer (CC) elimination strategy recommends to achieve a 70% coverage for CC screening and 90% of precancerous lesions treated in eligible women. We evaluated progress towards these WHO CC elimination targets according to HIV status in Côte d’Ivoire over the 2010-2021 period. Methods A CC screening registry was initiated in…